Nagasaka Takeshi, Goel Ajay, Notohara Kenji, Takahata Takaomi, Sasamoto Hiromi, Uchida Takuyuki, Nishida Naoshi, Tanaka Noriaki, Boland Clement Richard, Matsubara Nagahide
Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
Int J Cancer. 2008 Jun 1;122(11):2429-36. doi: 10.1002/ijc.23398.
O(6)-methylguanine-DNA methyltransferase (MGMT) is a DNA repair gene which is frequently methylated in colorectal cancer (CRC). However, it remains controversial whether methylation of specific CpG sequences within MGMT promoter leads to loss of its protein expression, and if MGMT methylation correlates with G to A transition mutations in KRAS. Two methylation sensitive regions (Mp and Eh region) of MGMT promoter were investigated in 593 specimens of colorectal tissue: 233 CRCs, 104 adenomatous polyps (AP), 220 normal colonic mucosa from CRC patients (N-C) and 36 normal colonic mucosa specimens obtained from subjects without colorectal neoplasia (N-N) by combined bisulfite restriction analysis (COBRA). The region-specific methylation data were compared to the MGMT protein expression, spectrum of KRAS mutations and other clinical features. Extensive (including both Mp and Eh) and partial (either Mp or Eh) MGMT methylation were found in 24.5% and 11.6% of CRCs, 3.8% and 27.9% of APs, 0.5% and 7.7% of C-Ns and 2.8% and 2.8% of N-Ns, respectively. Extensive methylation of MGMT promoter was primarily present in CRCs while partial methylation was common in APs. Extensive methylation of MGMT promoter was associated with loss/reduced protein expression (p < 0.0001), as well as with G to A mutations in KRAS (p = 0.0017). We herein provide first evidence that extensive methylation of MGMT promoter region is essential for methylation-induced silencing of this gene. Our data suggest that MGMT methylation may evolve and spread throughout the promoter in a stepwise manner as the colonic epithelial cells progress through the classical-adenoma-cancer multistep cascade.
O(6)-甲基鸟嘌呤-DNA甲基转移酶(MGMT)是一种DNA修复基因,在结直肠癌(CRC)中经常发生甲基化。然而,MGMT启动子内特定CpG序列的甲基化是否导致其蛋白质表达缺失,以及MGMT甲基化是否与KRAS基因中G到A的转换突变相关,仍存在争议。通过联合亚硫酸氢盐限制性分析(COBRA),在593例结直肠组织标本中研究了MGMT启动子的两个甲基化敏感区域(Mp和Eh区域):233例CRC、104例腺瘤性息肉(AP)、220例CRC患者的正常结肠黏膜(N-C)以及36例无结直肠肿瘤受试者的正常结肠黏膜标本(N-N)。将区域特异性甲基化数据与MGMT蛋白表达、KRAS突变谱及其他临床特征进行比较。在CRC中,分别有24.5%和11.6%发现广泛(包括Mp和Eh)和部分(Mp或Eh)MGMT甲基化;在AP中分别为3.8%和27.9%;在C-N中分别为0.5%和7.7%;在N-N中分别为2.8%和2.8%。MGMT启动子的广泛甲基化主要存在于CRC中,而部分甲基化在AP中常见。MGMT启动子的广泛甲基化与蛋白表达缺失/降低相关(p < 0.0001),也与KRAS基因中G到A的突变相关(p = 0.0017)。我们在此首次提供证据表明,MGMT启动子区域的广泛甲基化对于该基因甲基化诱导的沉默至关重要。我们的数据表明,随着结肠上皮细胞通过经典的腺瘤-癌多步骤级联进展,MGMT甲基化可能会逐步在启动子中演变和扩散。